Mark D. Bednarski
24Patents
14h-index
23Co-inventors
81Inventor score
Filing activity: Apr 15, 1991 → Feb 26, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5736625A | Method for stabilizing proteins with saccharide linked protein polymer conjugates | Emerging Cross-Sectional Technologies | 108 | Expired |
| US5492821A | Stabilized polyacrylic saccharide protein conjugates | Emerging Cross-Sectional Technologies | 105 | Expired |
| US6066123A | Enhancement of bioavailability by use of focused energy delivery to a target tissue | Human Necessities | 84 | Expired |
| US5510481A | Self-assembled molecular films incorporating a ligand | Emerging Cross-Sectional Technologies | 75 | Expired |
| US6132764A | Targeted polymerized liposome diagnostic and treatment agents | Emerging Cross-Sectional Technologies | 68 | Expired |
| US5691154A | Enzyme linked immunoassay with stabilized polymer saccharide enzyme conjugates | Emerging Cross-Sectional Technologies | 49 | Expired |
| US5512294A | Targeted polymerized liposome contrast agents | Emerging Cross-Sectional Technologies | 42 | Expired |
| US7507842B2 | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | Chemistry; Metallurgy | 34 | Active |
| US6569451B1 | Targeted polymerized liposome diagnostic and treatment agents | Emerging Cross-Sectional Technologies | 22 | Expired |
| US8299053B2 | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | Chemistry; Metallurgy | 21 | Active |
| US6350466B1 | Targeted polymerized liposome diagnostic and treatment agents | Emerging Cross-Sectional Technologies | 17 | Expired |
| US8927527B2 | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | Chemistry; Metallurgy | 16 | Active |
| US5639633A | Method for synthesizing peptides with saccharide linked enzyme polymer conjugates | Emerging Cross-Sectional Technologies | 15 | Expired |
| US9226915B2 | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | Chemistry; Metallurgy | 14 | Active |
| US10149832B2 | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US5212075A | Compositions and methods for introducing effectors to pathogens and cells | Human Necessities | 10 | Expired |
| US6090408A | Use of polymerized lipid diagnostic agents | Emerging Cross-Sectional Technologies | 9 | Expired |
| US7025987B2 | Delivery system for nucleic acids | Human Necessities | 2 | Expired |
| US11925617B2 | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | Chemistry; Metallurgy | 2 | Active |
| US8163305B2 | Targeted cross-linked nanoparticles and their use in vivo gene delivery | Human Necessities | 1 | Active |
| US7514098B2 | Use of targeted cross-linked nanoparticles for in vivo gene delivery | Human Necessities | 1 | Expired |
| US8530681B2 | Pharmaceutical compositions of O-nitro compounds | Human Necessities | 0 | Active |
| US7803399B2 | Delivery system for nucleic acids | Human Necessities | 0 | Active |
| US9133150B2 | O-nitro compounds and pharmaceutical compositions including same | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.